Literature DB >> 20124508

Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress.

Lele Ji1, Feng Fu, Lihua Zhang, Wenchong Liu, Xiaoqing Cai, Lei Zhang, Qiangsun Zheng, Haifeng Zhang, Feng Gao.   

Abstract

It is well known that insulin possesses a cardioprotective effect and that insulin resistance is closely related to cardiovascular diseases. Peroxynitrite (ONOO(-)) formation may trigger oxidative/nitrative stress and represent a major cytotoxic effect in heart diseases. This study was designed to investigate whether insulin attenuates ONOO(-) generation and oxidative/nitrative stress in acute myocardial ischemia/reperfusion (MI/R). Adult male rats were subjected to 30 min of myocardial ischemia and 3 h of reperfusion. Rats randomly received vehicle, insulin, or insulin plus wortmannin. Arterial blood pressure and left ventricular pressure were monitored throughout the experiment. Insulin significantly improved cardiac functions and reduced myocardial infarction, apoptotic cell death, and blood creatine kinase/lactate dehydrogenase levels following MI/R. Myocardial ONOO(-) formation was significantly attenuated after insulin treatment. Moreover, insulin resulted in a significant increase in Akt and endothelial nitric oxide (NO) synthase (eNOS) phosphorylation, NO production, and antioxidant capacity in ischemic/reperfused myocardial tissue. On the other hand, insulin markedly reduced MI/R-induced inducible NOS (iNOS) and gp91(phox) expression in cardiac tissue. Inhibition of insulin signaling with wortmannin not only blocked the cardioprotection of insulin but also markedly attenuated insulin-induced antioxidative/antinitrative effect. Furthermore, the suppression on ONOO(-) formation by either insulin or an ONOO(-) scavenger uric acid reduced myocardial infarct size in rats subjected to MI/R. We concluded that insulin exerts a cardioprotective effect against MI/R injury by blocking ONOO(-) formation. Increased physiological NO production (via eNOS phosphorylation) and superoxide anion reduction contribute to the antioxidative/antinitrative effect of insulin, which can be reversed by inhibiting phosphatidylinositol 3'-kinase. These results provide important novel information on the mechanisms of cardiovascular actions of insulin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20124508     DOI: 10.1152/ajpendo.00623.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  50 in total

1.  Protective effect of propofol and its relation to postoperation recovery in children undergoing cardiac surgery with cardiopulmonary bypass.

Authors:  Wen-fang Xia; Yu Liu; Qing-shan Zhou; Qi-zhu Tang; Han-dong Zou
Journal:  Pediatr Cardiol       Date:  2011-06-03       Impact factor: 1.655

2.  Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury.

Authors:  Silvio Antoniak; Mauricio Rojas; Denise Spring; Tara A Bullard; Edward D Verrier; Burns C Blaxall; Nigel Mackman; Rafal Pawlinski
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-19       Impact factor: 8.311

3.  Comparison of the effects of propofol and midazolam on inflammation and oxidase stress in children with congenital heart disease undergoing cardiac surgery.

Authors:  Wen-fang Xia; Yu Liu; Qing-shan Zhou; Qi-zhu Tang; Han-dong Zou
Journal:  Yonsei Med J       Date:  2011-03       Impact factor: 2.759

4.  Thioredoxin reductase was nitrated in the aging heart after myocardial ischemia/reperfusion.

Authors:  Ke Wang; Jie Zhang; Xiaoliang Wang; Xin Liu; Lin Zuo; Kehua Bai; Jianyu Shang; Lu Ma; Teng Liu; Li Wang; Wen Wang; Xinliang Ma; Huirong Liu
Journal:  Rejuvenation Res       Date:  2013-10       Impact factor: 4.663

5.  MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart.

Authors:  Carley Glass; Dinender K Singla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

6.  Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo.

Authors:  Noureddine Loukili; Nathalie Rosenblatt-Velin; Jianhui Li; Stéphanie Clerc; Pal Pacher; François Feihl; Bernard Waeber; Lucas Liaudet
Journal:  Cardiovasc Res       Date:  2010-11-26       Impact factor: 10.787

7.  Overexpression of microRNA-145 protects against rat myocardial infarction through targeting PDCD4.

Authors:  Hao Xu; Heng Cao; Guoqing Zhu; Shaowen Liu; Hongli Li
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  Shen-Fu injection preconditioning inhibits myocardial ischemia-reperfusion injury in diabetic rats: activation of eNOS via the PI3K/Akt pathway.

Authors:  Yang Wu; Zhong-yuan Xia; Qing-tao Meng; Jie Zhu; Shaoqing Lei; Jinjin Xu; Juan Dou
Journal:  J Biomed Biotechnol       Date:  2010-11-29

9.  The selective 5-LOX inhibitor 11-keto-β-boswellic acid protects against myocardial ischemia reperfusion injury in rats: involvement of redox and inflammatory cascades.

Authors:  Shimaa M Elshazly; Dalia M Abd El Motteleb; Noha N Nassar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-15       Impact factor: 3.000

10.  Shexiang Tongxin Dropping Pill () Protects against Na2S2O4-Induced Hypoxia-Reoxygenation Injury in H9c2 Cells.

Authors:  Shan Lin; Jiu-Mao Lin; Ling Zhang; Da-Xin Chen; Fei Xiao; Hong-Wei Chen; You-Qin Chen; Yu-Ling Zhu; Jian-Feng Chu; Jun Peng
Journal:  Chin J Integr Med       Date:  2018-04-04       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.